Alteration of acetaminophen metabolism by sulfate and steroids in primary monolayer hepatocyte cultures of rats and mice

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 3, 1999, Pages 261-264

  Seo, Kyung Won ^a   Oh, Mi Hyun ^a   Choung, Se Young ^b   Kim, Sung Jin ^c   Kim, Hyo Jung ^a  

^a Korea Food and Drug Administration   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Mouse hepatocyte; Rat hepatocyte; Steroid; Sulfate; Sulfation

Indexed keywords

16ALPHA CYANOPREGNENOLONE; DEXAMETHASONE; GLUCURONOSYLTRANSFERASE; PARACETAMOL; STEROID; SULFATE; SULFOTRANSFERASE; XENOBIOTIC AGENT;

ANIMAL CELL; ARTICLE; DRUG METABOLISM; GLUCURONIDATION; LIVER CELL; LIVER CELL CULTURE; MALE; MOUSE; NONHUMAN; RAT; SULFATION;

EID: 0345471366     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.261     Document Type: Article

References (32)

1. Boyd E. M., Br. J. Pharmacol. Chemother., 26, 606-614 (1966).
2. Davidson D. G., Eastham W. N., Br. Med. J., 11, 497-499 (1966).
3. Hinson J. A., "Reviews in Biochemical Toxicology," ed. by Hodgson E., Bend J. R., Philpot R. M., Elsevier/North-Holland, New York, 1982, pp. 103-129.
4. Black M., Annu. Rev. Med., 35, 577-593 (1984).
5. Davies D. C., Potter W. Z., Jollow D. J., Mitchell J. R., Life Sci., 14, 2099-2109 (1974).
6. Siegers C. D., Strublet O., Schutt A., Pharmacology, 16, 273-278 (1978).
7. Jollow D. J., Robert S., Price V., Smith C., "Biochemical Reactive Intermediates II. Chemical Mechanisms and Biological Effects," ed. by Syner R., Paeke D. V., Kocois J. J., Gibson G., Jollow D. J., Plenum Press, New York, 1982, pp. 99-113.
8. Caldwell J., "Concepts in Drug Metabolism," ed. by Jenner P., Testa B., Marcel Dekker, Inc., New York, 1981, pp. 211-250.
9. Gregus Z., Madhu C., Klaassen C. D., J. Pharmacol. Exp. Ther., 244, 91-99 (1988).
10. Moldeus P., Biochem. Pharmacol., 27, 2859-2863 (1978).
11. Koster H., Halsema I., Scholtens E., Pang K. S., Mulder G. J., Biochem. Pharmacol., 31, 3023 -3028 (1982).
12. Krijgsheld K. R., Scholtens E., Mulder G. J., Biochem. Pharmacol., 30, 1973-1979 (1981).
13. Levy G., Galinsky R., Lin J. H., Drug Metab. Rev., 13, 1009-1020 (1982).
14. Thompson J. B., Watkins J. B., Gregus Z., Klaassen C. D., Toxicol. Appl. Pharmacol., 66, 400-408 (1982).
15. Liu L., Liu Y. P., Klaassen C. D., The Toxicologist, 14, 342 (1994).
16. Madhu C., Klaassen C. D., Toxicol. Appl. Pharmacol., 109, 305-313 (1991).
17. Madhu C., Maziasz T., Klaassen C. D., Toxicol. Appl. Pharmacol., 115, 191-198 (1992).
18. Williams G. M., Bermudez E., Scaramuzzino D., In Vitro, 13, 809-817 (1977).
19. Klaunig J. E., Goldblatt P. J., Hinton D. E., Lipsky M. M., Chacko J., Trump B. F., In Vitro, 17, 913-925 (1981).
20. Klaunig J. E., Goldblatt P. J., Hinton D. E., Lipsky M. M., Trump B. F., In Vitro, 17, 926-934 (1981).
21. Howie D., Adriaenssens P., Prescott L. O. F., J. Pharm. Pharmacol., 29, 235-237 (1977).
22. Lowry O. H., Rosebrough N. J., Fan A. L., Randall R. J., J. Biol. Chem., 193, 265-275 (1951).
23. Sweeny D. J., Reinke L. A., Drug Metab. Dispos., 16, 712-715 (1988).
24. Moldeus P., Andersson B., Gergely V., Drug Metab. Dispos., 7, 416-419 (1979).
25. Koike M., Sugeno K., Hirata M., J. Pharm. Sci., 70, 306-311 (1981).
26. Hjelle J. J., Hazelton G. A., Klaassen C. D., Drug Metab. Dispos., 13, 35-41 (1985).
27. Hazelton G. A., Klaassen C. D., Drug Metab. Dispos., 16, 30-36 (1987).
28. Arlotto M. P., Sonderfan A. J., Klaassen C. D., Parkinson A., Biochem. Pharmacol., 36, 3859-3866 (1988).
29. Richards L. G., Lage G. L., Toxicol. Appl. Pharmacol., 42, 309-318 (1977).
30. Castle M. C., Biochem. Pharmacol., 29, 1497-1502 (1980).
31. Watkins J. B., Gregus Z., Thompson J. B., Klaassen C. D., Toxicol. Appl. Pharmacol., 64, 439-446 (1982).
32. Watkins J. B., Klaassen C. D., Drug Metab. Dispos., 13, 186 (1985).